JEANNIE NOBLITT: Open Payments
NPI 1255326740 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 80 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,076 · 2025 $1,901
Food & beverage: $1,901
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $393 |
| CSL Behring | 11 | $324 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $239 |
| Amgen Inc. | 9 | $182 |
| Regeneron Healthcare Solutions, Inc. | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| GENZYME CORPORATION | 3 | $90 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Galderma Laboratories, L.P. | 3 | $59 |
| Optinose US, Inc. | 2 | $57 |
Products named: Hizentra, DUPIXENT, NEFFY, TEZSPIRE, FASENRA, AIRSUPRA, Xolair, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
